The incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in situ in patients with intraductal papilloma without atypia on core biopsy: results …

F Nakhlis, GM Baker, M Pilewskie, R Gelman… - Annals of surgical …, 2021 - Springer
Background Available retrospective data suggest the upgrade rate for intraductal papilloma
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …
被引用次数：33 相关文章

The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy …

F Nakhlis, GM Baker, M Pilewskie… - Annals of surgical …, 2021 - pure.johnshopkins.edu
Background: Available retrospective data suggest the upgrade rate for intraductal papilloma
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …

[引用][C] The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core …

F Nakhlis, GM Baker, M Pilewskie, R Gelman… - Annals of Surgical …, 2020 - cir.nii.ac.jp
The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in
Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective …

The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy …

N Faina, GM Baker, M Pilewskie… - Annals of Surgical …, 2021 - search.proquest.com
Background Available retrospective data suggest the upgrade rate for intraductal papilloma
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …

The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy …

F Nakhlis, GM Baker, M Pilewskie… - Annals of Surgical …, 2020 - europepmc.org
Background Available retrospective data suggest the upgrade rate for intraductal papilloma
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …

The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy …

F Nakhlis, GM Baker, M Pilewskie… - Annals of surgical …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Available retrospective data suggest the upgrade rate for intraductal papilloma
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …

The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy …

F Nakhlis, GM Baker, M Pilewskie… - Annals of Surgical …, 2021 - einstein.elsevierpure.com
Background: Available retrospective data suggest the upgrade rate for intraductal papilloma
(IP) without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …